ijmedicine

INTERNATIONAL JOURNAL OF ADVANCED MEDICINE (IJAM)

ISSN (O) : 2663 - 046X

A CrossRef Indexed Journal

DOI : 10.34300/26630451

ISSN (P) : 2663 - 0451

IC VALUE : 89.03 (2020)

International Journal of Advanced Medicine (IJAM)
Research Paper

Prevalence Of Primary Drug Resistance To Rifampicin And Isoniazid In Newly Diagnosed Sputum Smear Positive Pulmonary Tuberculosis

Dr Ashok Kumar, Dr Jawahar Lal Joshi, Dr Abdurazack Umathoor, Dr Vishal Chopra, Dr Komaldeep Kaur, Dr Vidhu Mittal

Abstract :

Aims and objective: To determine the prevalence of primary drug resistance to either rifampicin or isoniazid alone or both in newly diagnosed sputum smear positive pulmonary tuberculosis patients.Material and method: A prospective study 100 newly diagnosed sputum smear positive pulmonary TB patients was conducted. The patients with an age of 15 years and who had either not taken anti TB treatment or who had taken ATT for less than 1 month were enrolled in this study. Two sputum samples (5ml each), including one early morning sample as per the RNTCP guidelines were collected and subjected to line probe assay (LPA).Results: Out of 100 cases 6 were having resistance to both rifampicin and isoniazid, 9 has resistance to INH alone and 1 had resistance to rifampicin alone.Conclusion: The prevalence of primary drug resistance is high. For early and rapid detection of DR-TB newer modality should be used for the detection of primary drug resistance in sputum smear positive TB patients.

Keywords :

MDRTB   Prevalence   Resistance  

Cite This Article:

PREVALENCE OF PRIMARY DRUG RESISTANCE TO RIFAMPICIN AND ISONIAZID IN NEWLY DIAGNOSED SPUTUM SMEAR POSITIVE PULMONARY TUBERCULOSIS, Dr Ashok Kumar, Dr Jawahar Lal Joshi, Dr Abdurazack Umathoor, Dr Vishal Chopra, Dr Komaldeep Kaur, Dr Vidhu Mittal, INTERNATIONAL JOURNAL OF ADVANCED MEDICINE : Volume-3 | Issue-5 | September-2019

References :


[ Download PDF] [ Number of Downloads : 419 ]


Calendar
This work is licensed under a Creative Commons Attribution 4.0 International License.
Disclaimer: Articles on International Journal of Advanced Medicine have been previewed and authenticated by the Authors before sending the publication for print.
The Journal, Editor and the editorial board are not entitled or liable to either justify or responsible for inaccurate and misleading data if any.
It is the sole responsibility of the Author concerned. If any queries or infringement occurs

Copyrights ©2022: International Journal of Advanced Medicine (IJAM)